Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Crispr Therapeutics AG (CRSP)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Crispr Therapeutics's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
53.92 +0.19    +0.35%
15:53:08 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 1,135,154
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 52.81 - 54.94
Crispr Therapeutics 53.92 +0.19 +0.35%

CRSP Recent Sentiments

 
This page contains information on users’ sentiments for the Crispr Therapeutics AG stock, which are displayed both on charts of different periods of time and on a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
Apr 26, 2024 Bruno Schuler   53.85 +0.13%
Apr 25, 2024 Mundo Koh   53.11 Apr 25, 2024 @ 53.41 +0.56%
Apr 25, 2024 Manuel BM   52.99 +1.76%
Apr 23, 2024 gimmyx gas   56.48 -4.53%
Apr 23, 2024 João Santos   56.79 -5.05%
Apr 23, 2024 Lin Tayar   57.89 +6.86%
Apr 19, 2024 Mubariz Eliyev   55.31 Apr 22, 2024 @ 55.02 -0.52%
Apr 18, 2024 Florin M Pop   55.53 Apr 22, 2024 @ 55.02 -0.92%
Apr 16, 2024 제윤 모   58.69 Apr 22, 2024 @ 55.02 -6.25%
Apr 12, 2024 Florin M Pop   62.53 Apr 15, 2024 @ 60.41 -3.39%
Apr 11, 2024 Jörg Holl   61.11 Apr 15, 2024 @ 60.41 -1.15%
Apr 11, 2024 Jill Fisher   62.00 Apr 15, 2024 @ 60.41 +2.56%
Apr 10, 2024 Radagast el pardo   60.92 -11.49%
Apr 10, 2024 Mark Pycroft   60.77 -11.27%
Apr 08, 2024 אילון אילון   63.24 Apr 08, 2024 @ 63.34 -0.16%
Apr 05, 2024 חיים פקר   62.83 -14.18%
Apr 04, 2024 La Paul   66.28 -18.65%
Apr 04, 2024 지우 황   66.45 -18.86%
Apr 04, 2024 Florin M Pop   64.60 Apr 08, 2024 @ 63.34 -1.95%
Apr 03, 2024 אביהו פנחס   64.85 -16.85%
Apr 03, 2024 Ga Bo   64.90 Apr 08, 2024 @ 63.34 -2.40%
Apr 02, 2024 Fer Fer fer   64.69 +16.65%
Apr 01, 2024 채민 조   67.90 -20.59%
Apr 01, 2024 Piero Rebosio   68.37 Apr 01, 2024 @ 66.93 -2.11%
Mar 27, 2024 Eitan Raz   70.98 Apr 01, 2024 @ 66.93 -5.71%
Mar 21, 2024 Irit Benjamin   74.16 Mar 25, 2024 @ 71.18 -4.02%
Mar 19, 2024 Jose Manuel   72.07 Apr 12, 2024 @ 60.67 -15.82%
Mar 15, 2024 FRITZ Jean Marie   72.17 Apr 05, 2024 @ 62.90 -12.84%
Mar 14, 2024 John Hilscher   75.24 Mar 18, 2024 @ 73.35 -2.51%
Mar 13, 2024 gimmyx gas   74.81 Apr 05, 2024 @ 62.90 -15.92%
Mar 13, 2024 예준 이   75.37 Apr 05, 2024 @ 62.90 -16.55%
Mar 12, 2024 Piermauro Bignotti   75.63 Apr 05, 2024 @ 62.90 -16.83%
Mar 11, 2024 oleg scherbinin   77.31 Apr 05, 2024 @ 62.90 -18.64%
Mar 07, 2024 Martin Walpen   80.85 Mar 29, 2024 @ 68.16 -15.70%
Mar 07, 2024 Florin M Pop   80.75 Mar 29, 2024 @ 68.16 -15.59%
Mar 07, 2024 John Klemmer   80.95 Mar 29, 2024 @ 68.16 -15.80%
Mar 06, 2024 Oumar Moctar   80.67 Mar 29, 2024 @ 68.16 -15.51%
Feb 29, 2024 Nabil Khalil   84.47 Mar 22, 2024 @ 71.61 -15.22%
Feb 29, 2024 Julia Rubin   84.95 Mar 22, 2024 @ 71.61 +15.70%
Feb 29, 2024 דניאל אויזרט   83.40 Mar 22, 2024 @ 71.61 -14.14%
Feb 28, 2024 Irit Benjamin   89.25 Mar 04, 2024 @ 80.81 -9.46%
Feb 27, 2024 Marius Gamissans   89.08 Mar 22, 2024 @ 71.61 -19.61%
Feb 27, 2024 Arham Humayun   86.79 Mar 22, 2024 @ 71.61 -17.49%
Feb 27, 2024 Florin M Pop   86.62 Mar 04, 2024 @ 80.81 -6.71%
Feb 26, 2024 Piero Rebosio   83.92 Feb 26, 2024 @ 84.89 +1.16%
Feb 23, 2024 Chloe Li   84.04 Mar 15, 2024 @ 72.95 -13.20%
Feb 23, 2024 סיון זמיר   83.18 Mar 15, 2024 @ 72.95 -12.30%
Feb 22, 2024 Jorge Garcia   90.28 Mar 15, 2024 @ 72.95 -19.20%
Feb 22, 2024 Irit Benjamin   89.65 Feb 26, 2024 @ 84.89 -5.31%
Feb 21, 2024 moshe kaduri   80.37 Mar 15, 2024 @ 72.95 +9.23%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CRSP Comments

Write your thoughts about Crispr Therapeutics AG
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Anthony Hernandez
Anthony Hernandez Jan 05, 2024 10:06AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Editing your genes to live a longer? Or all the gold in the world?
John Brand
John Brand Dec 14, 2023 6:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Gap filled.
fth Jung
fth Jung Dec 11, 2023 11:38AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Absurd
Mark Mallonee
Mark Mallonee Dec 08, 2023 4:30PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Take note that another sickle cell stock, a compeititor to CRISPR, was ALSO approved today. It ALSO plummeted today in value, by 40%!The reasons for these drops are vastly different in the end and are why CRISPR is showing to be the likely winner in this field for 2 reasons:- Bluebird earned a black box warning for certain kinds of blood cancer today with its approval. I am a second year pharmacy student. In case you don’t know what a black box warning is, it’s the most dangerous, important, in your face side effect that practitioners MUST see before they prescribe treatments. This BBW is particularly nasty it seems, truly.- It has been announed that CRISPR will be almost 1 million dollars cheaper than bluebird’s treatment. That is huge. Bluebird will cost 3.1 million for treatment and CRISPR will cost 2.2 million for treatment. Bluebird costs more and has a horrib black box warning. CRISPR is cheaper and had NO black box warning given to it today. CRISPR is the obvious choice.
Mark Mallonee
Mark Mallonee Dec 08, 2023 4:30PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
That other company is bluebird, in case I did not make it clear at the start of my comment.
Simon Frandsen
Simon Frandsen Dec 08, 2023 4:30PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Thanks for good info and thoughts Mark
Robby Lester
Robby Lester Dec 08, 2023 2:39PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Took profits. Buy back in at $50
Otis Grant
Otis Grant Dec 08, 2023 1:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Dont panic the same thing happened with the UK approval. The rally took a little bit to start
fth Jung
fth Jung Dec 08, 2023 1:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
How long?
Mark Mallonee
Mark Mallonee Dec 08, 2023 11:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Anyone able to determine why the drop?
Grape Ape
Grape Ape Dec 08, 2023 11:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Options tomfoolery. The zero day derivatives market has gotten cartoonishly large.
Nicholas Murphy
Nicholas Murphy Dec 08, 2023 11:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
They slashed 10% of their staff. Never good. But FDA approval is huge. Just have faith in the play. Takes a while for the big boys to get in.
Luca Origo
Luca Origo Dec 08, 2023 11:49AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
It should skyrocket 30% up and it goes down wtf
Grape Ape
Grape Ape Dec 08, 2023 11:47AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Brutal, lol
Grape Ape
Grape Ape Dec 08, 2023 11:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Gotta love approving a Nobel award winning, first of its kind DNa editing treatment for nearly 100,000 people means an instant 8% drop, lol. Guess we just gotta hold and wait.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email